Skip to content

DOKTER J. VAN LIERDE

Active Private limited companyfounded 1995active for 31 yearsOude Postbaan 33, 3600 GenkKBO/BCE: BE 0456.393.413

Lifetime

24 annual accounts with figures on one time axis, 29 filings since 1996
peak of €658,600 in 2006
€421,467▲ 10.5%
lowest -€29,455 in 2010
€235,372▲ 4.6%
peak of €2.1m in 2025
€2.1m▲ 12.8%
€27,157▼ 27.6%
Board2 names since 2015
2 directors and 1 other
Documentsfilings and deeds
31-07-2026on the last day
2025micro format
Equity from €1.8m to €2.1mDebts from €37,513 to €27,157Cash from €404,970 to €583,155

Key points

from the 2025 annual accounts

Equity

€2.1m ▲ 12.8%

DOKTER J. VAN LIERDE has made a profit without a break since 2011.

Filings

29 annual accounts since 1996
AprilJune31 JulyOctober200020102020

Nine of the last ten came late. The 2019 accounts came in latest, 40 days after the end of the period.

Position in the sector

98.7%

Higher solvency than 95% of companies in human health. The sector median is 63.0%, over 21,397 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,155 companies had the same profile as DOKTER J. VAN LIERDE has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,155 companies, not a prediction for DOKTER J. VAN LIERDE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • deed of 09-12-2013

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0456393413
Capital decrease of €710,289.05 resigns as manager · reappointed as director · General meeting of 03-03-2020 · Gazette deed
reappointed as manager General meeting of 30-10-2015 · Gazette deed
Capital increase of €710,289.05 to €784,789.05 The capital rose from €74,500 to €784,789.05 · Contribution by · appointed as company auditor · General meeting of 15-11-2013 · Gazette deed
All 48 events

Comparable companies

same main activity, similar in size and age
Company
DOKTER J. VAN LIERDE Genk €2.1m €421,467 98.7% -
DOKTERSPRAKTIJK LUDO NIJS NEURO-HEALTH EN PAIN CENTER Hasselt €2.4m €412,038 88.6% -
DR. KOENRAAD VAN RENTERGHEM UROLOOG Zonhoven €2.3m €388,353 55.7% -
DOKTER M.P.P. ROSSEEL Aalst €2.1m €456,717 91.5% -
CABINET MEDICAL DE MOLENBEEK Molenbeek-Saint-Jean €1.9m €406,866 89.2% 3.5
MEDROEL Ypres €2.4m €459,590 64.2% -
DOKTER GUBBELMANS HENDRIK Genk €2.3m €473,164 98.9% -

These companies have the same main activity as DOKTER J. VAN LIERDE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.9m and €2.4m, founded between 1992 and 2001.

Official details

Source: KBO
Status
Active since 30-10-1995Normal situation
Activity
Specialist medical practiceNACE 86220
Financial year end
31 December
Peppol
Reachable since 26-10-2025
Company details

Annual accounts 2025

≈ €630,000estimated
€2.1m▲ 12.0%
Filing
Filed on 31-07-2026, on the last day of the filing period
Financials

Insights on DOKTER J. VAN LIERDE

DOKTER J. VAN LIERDE files the micro format. That format states no turnover. The gross margin rose from €234,993 in 2002 to €421,467 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOKTER J. VAN LIERDE

What is the company number of DOKTER J. VAN LIERDE?
The company number of DOKTER J. VAN LIERDE is 0456.393.413. The VAT number is the same number with BE in front: BE 0456.393.413.
Where is DOKTER J. VAN LIERDE based?
The registered office is at Oude Postbaan 33, 3600 Genk.Company details
What does DOKTER J. VAN LIERDE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOKTER J. VAN LIERDE?
DOKTER J. VAN LIERDE is a private limited company (BV).
When was DOKTER J. VAN LIERDE founded?
DOKTER J. VAN LIERDE was founded on 30-10-1995.
Is DOKTER J. VAN LIERDE still active?
Yes, DOKTER J. VAN LIERDE is an active enterprise in the KBO register.
What is the turnover of DOKTER J. VAN LIERDE?
The turnover in financial year 2025 is about €630,000. This figure is estimated from the gross margin of €421,467 and 31 comparable companies (NACE 86220). It probably lies between €560,000 and €880,000.Financials
Is DOKTER J. VAN LIERDE profitable?
In financial year 2025, DOKTER J. VAN LIERDE made a profit of €235,372.
Where can I find the annual accounts of DOKTER J. VAN LIERDE?
DOKTER J. VAN LIERDE filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER J. VAN LIERDE due?
DOKTER J. VAN LIERDE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.